1-7 of 7
Eric Leifer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis

Sameem Abedin, Qinghua Lian, Michael J Martens, MHD Monzr M. Al Malki, Hany Elmariah, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Alison W Loren, Melhem M. Solh, Amin M. Alousi, Omer Jamy, Janny M. Yao, Kristy Applegate, Miguel Angel Perales, Leslie Kean, Yvonne A. Efebera, Ran Reshef, William Clark, Eric Leifer, Mary M. Horowitz, Richard J. Jones, Javier Bolanos-Meade, Shernan G. Holtan, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 1042.
https://doi.org/10.1182/blood-2024-193827
Published: 2024
Journal Articles

Likelihood of finding an 8/8 HLA-matched unrelated donor (Donor Search Prognosis) is not associated with survival: Primary results from BMT CTN 1702

Stephanie J. Lee, Brent R. Logan, Mary M. Horowitz, Peter Westervelt, William J. Hogan, Joseph A. Pidala, Jason Dehn, Brandon Hayes-Lattin, Nosha Farhadfar, Asad Bashey, Michael R. Grunwald, Samer A. Srour, Claudio Brunstein, Heather Jill Symons, Joseph Uberti, Iskra Pusic, Eric Leifer, Naya He, Steven M. Devine, Bronwen E. Shaw, Stefan O. Ciurea
Journal: Blood
Blood (2024) 144 (Supplement 1): 695.
https://doi.org/10.1182/blood-2024-200833
Published: 2024
Journal Articles

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial

Clinical Trials & Observations
Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen, Brent Logan, Joseph H. Antin, Peter Dawson, Steven Devine, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, Eric Leifer, John M. Magenau, Joseph P. McGuirk, Lawrence E. Morris, Andrew R. Rezvani, Richard J. Jones, Claudio G. Brunstein
Journal: Blood
Blood (2021) 137 (3): 420–428.
https://doi.org/10.1182/blood.2020007535
Published: 2021
Includes: Supplemental data
Journal Articles

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

Ryotaro Nakamura, MD, Wael Saber, MD MS, Michael J Martens, PhD, Alyssa Ramirez, Bart L. Scott, MD, Betul Oran, MDMS, Eric Leifer, PhD, Roni Tamari, MD, Asmita Mishra, MD, Richard T. Maziarz, MD, Joseph P. McGuirk, DO, Peter Westervelt, MD PhD, Sumithra Vasu, MDMBBS, Mrinal M. Patnaik, MDMBBS, Rammurti Kamble, MD, Stephen J. Forman, MD, Mikkael A. Sekeres, Frederick R. Appelbaum, MD, Adam M. Mendizabal, MS, Brent Logan, PhD, Mary M. Horowitz, MD MS, Corey Cutler, MD MPH, FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–21.
https://doi.org/10.1182/blood-2020-136828
Published: 2020
Journal Articles

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

Bart L Scott, MD, Marcelo C. Pasquini, MD, Brent Logan, PhD, Juan Wu, Steve Devine, MD, David L Porter, MD, Richard T. Maziarz, MD, Erica Warlick, MD, Hugo F. Fernandez, M.D., Edwin P. Alyea, MD, Mehdi Hamadani, MD, Asad Bashey, MD, PhD, Sergio A. Giralt, MD, Eric Leifer, PhD, Nancy Geller, PhD, Jennifer Le-Rademacher, PhD, Adam M. Mendizabal, PhD, Mary M. Horowitz, MD, MS, H. Joachim Deeg, MD, Mitchell E. Horwitz, MD
Journal: Blood
Blood (2015) 126 (23): LBA-8.
https://doi.org/10.1182/blood.V126.23.LBA-8.LBA-8
Published: 2015
Journal Articles

Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

Paolo Anderlini, MD, Juan Wu, MS, H. Joachim Deeg, MD, Iris Gersten, MS, Marian Ewell, ScD, Jakub Tolar, MD PhD, Joseph H. Antin, MD, Sally Arai, MD, Mitchell E. Horwitz, MD, John M. McCarty, MD, Ryotaro Nakamura, MD, Michael A. Pulsipher, MD, Roberta H. Adams, MD, Eric Leifer, PhD, Shelly L Carter, ScD, Nancy L DiFronzo, PhD, Mary M. Horowitz, MD MS, Dennis L. Confer, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2014) 124 (21): 541.
https://doi.org/10.1182/blood.V124.21.541.541
Published: 2014
Journal Articles

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia (SAA): Serious and Unexpected Adverse Events in Pre-Defined Cyclophosphamide (CY) Dose Levels

Jakub Tolar, MD, PhD, H. Joachim Deeg, M.D., Sally Arai, MD, Mitchell Horwitz, MD, Joseph H. Antin, MD, John M. McCarty, MD, Roberta H. Adams, MD, Mary Eapen, MBBS, Marian Ewell, ScD, Eric Leifer, PhD, Iris Gersten, MS, Shelly L Carter, ScD, Mary M. Horowitz, MD, Dennis L Confer, MD, Ryotaro Nakamura, MD, Michael Pulsipher, MD, Nancy L DiFronzo, PhD, Paolo Anderlini, MD
Journal: Blood
Blood (2011) 118 (21): 3009.
https://doi.org/10.1182/blood.V118.21.3009.3009
Published: 2011